HIV trials recruiting in Washington

All HIV trials nationally

Cities in Washington

Recruiting trials in Washington

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
  NCT07266831 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle
• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · Washington: Seattle
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Washington: Seattle
• A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
  NCT07202546 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Washington: Seattle
• A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
  NCT07569029 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Washington: Seattle
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
  NCT06665646 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Washington: Seattle
• Dasatinib for HIV-1 Reservoir Reduction
  NCT07342491 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle
• Effect of High-Intensity Exercise to Attenuate Cognitive Function Limitations and Train Exercise Habits in Older People Living With HIV
  NCT06013579 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · Washington: Seattle
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
  NCT04949464 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · Washington: Seattle
• Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests
  NCT04880200 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle
• Positive Peers Intervention Clinical Trial
  NCT06388109 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 34 Years · Sex: All (male and female) · Washington: Seattle
• Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV
  NCT07105007 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: All (male and female) · Washington: Seattle
• Single Session Narrative Therapy Study
  NCT06479980 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle
• Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
  NCT07682961 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle
• Trial of Ixazomib for Kaposi Sarcoma
  NCT04305691 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Washington: Seattle
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · Washington: Seattle